StockWatch
·
Pharmaceuticals
Insider Trading28 Sept 2026, 10:48 am

Vivanza Biosciences Closes Trading Window for Q2 FY27 Results

AI Summary

Vivanza Biosciences Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be shut from October 1, 2026, until 48 hours after the declaration of the company's unaudited financial results for the quarter and half-year ending September 30, 2026. During this period, no transactions involving the company's securities are permitted for insiders.

Key Highlights

  • Trading window closed for designated persons and relatives.
  • Closure effective from October 1, 2026.
  • Period extends 48 hours post Q2 FY27 results declaration.
  • Aims to prevent insider trading as per SEBI regulations.